Navigation Links
Volcano Corporation Prices Offering Of $400 Million 1.75% Convertible Senior Notes Due 2017
Date:12/5/2012

registration statement filed with the Securities and Exchange Commission ("SEC") on September 13, 2010, which was effective upon filing.  Before you invest, you should read the prospectus and prospectus supplement, when available, to that registration statement and other documents Volcano has filed with the SEC for more complete information about Volcano and this offering. You may get these documents at the SEC web site at www.sec.gov. Printed copies of the prospectus supplement relating to this offering, when available, may also be obtained by requesting copies from J.P. Morgan Securities LLC, Attention: Broadridge Financial Solutions at 1155 Long Island Avenue, Edgewood, New York 11717, or by telephone at 866-803-9204, or from Goldman, Sachs & Co., Attention: Prospectus Department at 200 West Street, New York, New York 10282, or by telephone at 866-471-2526, or by e-mailing prospectus-ny@ny.email.gs.com.

This press release does not constitute an offer to sell or the solicitation of an offer to buy securities, nor shall there be any sales of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any jurisdiction.mu

About Volcano Corporation

Volcano Corporation is revolutionizing the medical device industry with a broad suite of technologies that make imaging and therapy simpler, more informative and less invasive. Our products empower physicians around the world with a new generation of analytical tools that deliver more meaningful information—using light and sound as the guiding elements. Founded in cardiovascular care and expanding into other specialties, Volcano is changing the assumption about what is possible in improving patient outcomes by combining imaging and therapy together.

Forward-Looking Information

This press releas
'/>"/>

SOURCE Volcano Corporation
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Volcano Corporation Presentation At JMP Securities Conference To Be Webcast
2. Volcano to Highlight its Leadership in Precision Guided Therapy at EuroPCR 2012
3. Volcano Corporation Presentation At Jefferies Conference To Be Webcast
4. Volcano Corporation Presentation at Wells Fargo Conference to be Webcast
5. Volcano Corporation Schedules Second Quarter Conference Call, Webcast
6. Volcano Corporation Reports 13 Percent Growth In Second Quarter Revenues; FFR Disposable Revenues Increase 38 Percent
7. Volcano Corporation Presentation At Canaccord Genuity Conference To Be Webcast
8. FAME 2 Published in the New England Journal of Medicine, Volcano participates in the $84M NIH-Sponsored ISCHEMIA Trial
9. Volcano Corporation Presentation At Stifel Nicolaus Conference To Be Webcast
10. Volcano Announces Previous St. Jude Medical Products Infringe Volcano Patent and Jury Verdicts in Patent Trials with St. Jude Medical
11. Volcano Corporation Schedules Third Quarter Conference Call, Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... NEWPORT BEACH, Calif. , June 17, 2013 /PRNewswire-iReach/ ... healthcare financing options for consumers, including gastric bypass and ... hired additional staff in order to effectively contact as ... services. The increase in staff is all part of ... in order to assist patients with both good and ...
(Date:6/17/2013)... DEERFIELD, Ill. and OSAKA, Japan ... Company Limited (Takeda) and its wholly-owned subsidiary, Takeda Pharmaceuticals ... NESINA (alogliptin) and the fixed-dose combination therapies KAZANO (alogliptin ... now available by prescription in pharmacies in ... approved by the U.S. Food and Drug Administration (FDA) ...
(Date:6/17/2013)... YORK , June 14, 2013 The law ... just commenced what is believed to be the first suit ... of pancreatic cancer in the user of two common anti-diabetic ... by Staten Island resident Robert ... Amylin Pharmaceuticals, LLC, et al., E.D.N.Y. CV 13-3411. ...
Breaking Medicine Technology:United Medical Credit Hires More Staff to Contact Doctors and Promote their Financing Services 2United Medical Credit Hires More Staff to Contact Doctors and Promote their Financing Services 3Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States 2Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States 3Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States 4Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States 5Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States 6Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States 7Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States 8Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States 9Suit filed for Pancreatic Cancer By Use of Byetta, Januvia and Janumet 2
... (ERT), (Nasdaq: ERT ) a global ... to biopharmaceutical and healthcare organizations and the market leader ... in drug development, announced today results for the ... noted, all comparative numbers refer to changes from ...
... MOUNTAIN VIEW, Calif., Aug. 1, 2011 VIVUS, Inc. ... development and commercialization of novel therapeutic products, today reported its financial ... 2011. Second Quarter ResultsFor the second quarter ... million, or $0.20 per share, as compared to a net loss ...
Cached Medicine Technology:ERT Reports Second Quarter 2011 Operating Results 2ERT Reports Second Quarter 2011 Operating Results 3ERT Reports Second Quarter 2011 Operating Results 4ERT Reports Second Quarter 2011 Operating Results 5ERT Reports Second Quarter 2011 Operating Results 6ERT Reports Second Quarter 2011 Operating Results 7ERT Reports Second Quarter 2011 Operating Results 8ERT Reports Second Quarter 2011 Operating Results 9ERT Reports Second Quarter 2011 Operating Results 10ERT Reports Second Quarter 2011 Operating Results 11ERT Reports Second Quarter 2011 Operating Results 12ERT Reports Second Quarter 2011 Operating Results 13VIVUS Reports Second Quarter and First Six Months 2011 Financial Results 2VIVUS Reports Second Quarter and First Six Months 2011 Financial Results 3VIVUS Reports Second Quarter and First Six Months 2011 Financial Results 4VIVUS Reports Second Quarter and First Six Months 2011 Financial Results 5VIVUS Reports Second Quarter and First Six Months 2011 Financial Results 6VIVUS Reports Second Quarter and First Six Months 2011 Financial Results 7
(Date:6/17/2013)... NY (June 17, 2013) A team from the ... the Naomi Berrie Diabetes Center of Columbia University has ... reflect the features of maturity-onset diabetes of the young ... MODY patients to produce induced pluripotent stem (iPS) cells, ... a mouse, the stem cell-derived beta cells secreted insulin ...
(Date:6/17/2013)... 17, 2013 The Professional Center ... they are now open in Schertz. The ... counseling and access to educational support groups. , ... used to help with athletic performance, post traumatic ... center, Cheryl Camarillo, LCSW, works primarily with those ...
(Date:6/17/2013)... Pa. (PRWEB) June 17, 2013 Without ... worldwide is expected to almost double by 2025 to ... to join together to advance research for the debilitating ... innovative initiatives hold hope for a promising future in ... in research, focus on much-needed support for caregivers and ...
(Date:6/17/2013)... Toronto, Ontario (PRWEB) June 17, 2013 Reliable ... as it helps in having an internet portal that can ... to consider when they are executing their duties. Collecting fees ... if it is not carried out efficiently. In such cases, ... can ensure that the task can be carried out efficiently ...
(Date:6/17/2013)... 17, 2013 Registered Dietitian and Founder ... article today on Tatalou.com outlining her four ways to ... Tricks to Improve Memory ,” includes the benefits of ... video games. , Chevreau also introduces the importance ... in Brain Clarity, a product Chevreau created specifically ...
Breaking Medicine News(10 mins):Health News:NYSCF and Columbia researchers demonstrate use of stem cells to analyze causes, treatment of diabetes 2Health News:NYSCF and Columbia researchers demonstrate use of stem cells to analyze causes, treatment of diabetes 3Health News:Professional Center for Enhanced Performance Opens in Schertz 2Health News:World Leaders in Alzheimer’s Innovation to Discuss Progress, Collaboration at DIA Annual Meeting 2Health News:World Leaders in Alzheimer’s Innovation to Discuss Progress, Collaboration at DIA Annual Meeting 3Health News:World Leaders in Alzheimer’s Innovation to Discuss Progress, Collaboration at DIA Annual Meeting 4Health News:PayCanada Offers Link to Pay Services to its Customers 2Health News:4 Tricks to Improve Memory for Women 2
... Merit Medical,Systems, Inc. (Nasdaq: MMSI ), a ... in cardiology and radiology,procedures, announced today that the Company ... year ended December 31, 2007, after the,close of the ... will hold its investor conference call on the same ...
... Pharmaceuticals,Inc. (OTC Bulletin Board: LTUS) ("Lotus" or ... Republic of China ("PRC"), today,announced that Enze ... of Lotus, has implemented cost saving strategies, ... by approximately 50%., The environmentally-friendly strategies ...
... run on both conventional gasoline and stored electricity ... until more sustainable technology is developed, according to ... International Journal of Automotive Technology and Management, they ... slow development of more sustainable fuel-cell powered electric ...
... China, Feb. 7 /Xinhua-PRNewswire-FirstCall/ -- Shengtai,Pharmaceutical, Inc. ... Company"), a leading manufacturer and distributor of ... announced its CFO,Mr. Yizhao Zhang, will present ... Growth,Stock Conference in Dana Point, California., ...
... Moratorium on Bisphenol,A in Baby Bottles, Food and Beverage ... of state,and national environmental health organizations in the U.S. ... use of bisphenol A (BPA) in baby,bottles and other ... a,new study that demonstrates the toxic chemical BPA leaches ...
... 60 Percent Less ... Calories and Sugar, YUBA CITY, Calif., ... Growers Inc. has introduced,PlumSmart Light, a lower calorie version of the popular ... 11 grams of,sugar, PlumSmart Light is a delicious and fresh way to ...
Cached Medicine News:Health News:Merit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the Year Ended December 31, 2007 2Health News:Merit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the Year Ended December 31, 2007 3Health News:Lotus Pharmaceuticals, Inc. Implements Environmentally-friendly Cost Saving Strategies 2Health News:The trouble with hybrids 2Health News:Shengtai Pharmaceutical, Inc. to Present at Roth Conference 2Health News:Shengtai Pharmaceutical, Inc. to Present at Roth Conference 3Health News:Baby Bottles Leach Toxic Chemical, According to New U.S. and Canadian Study 2Health News:Baby Bottles Leach Toxic Chemical, According to New U.S. and Canadian Study 3Health News:Baby Bottles Leach Toxic Chemical, According to New U.S. and Canadian Study 4Health News:Sunsweet Introduces PlumSmart Light(R) 2
CDIs Abdominal Binders are designed with a non-pitching, body contouring, non-rolling elastic band that provides both support and compression. Available in 9, 12 and 15 widths with waist ranges from ...
Ideal for abdominal and flank procedures....
Male high waisted compression girdle with CDIs Wonderfabric™...
CDIs 2nd Stage Abdominoplasty Girdle - a feminine, easy pull-on version of the 8000 series...
Medicine Products: